glp-1 and ibs Benefits Beyond Weight Loss: IBS, PCOS, Risks GLP-1 and Microbiome Repair for
Description
The specificity of the signal (e.g., no increase in non-vestibular ENT diagnoses like hearing loss) further argues against pure detection bias
Semaglutide is a synthetic GLP-1 receptor agonist (glucagon-like peptide-1)
The overall discontinuation rate due to adverse events was approximately 10%, which compares favorably to most compounds in this class
But if the duration of treatment is limited will he come back to us in the same situation in 5 years time
Available online at: 28 LiaoJ.SuguroR.ZhaoX.YuY.CuiY.ZhuY
Recent Developments: Initiated Phase 3 trials for orforglipron, aiming to provide an oral alternative to injectable GLP-1 drugs
